{"Title": "Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: A multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing", "Year": 2015, "Source": "J. Antimicrob. Chemother.", "Volume": "70", "Issue": 3, "Art.No": null, "PageStart": 930, "PageEnd": 940, "CitedBy": 79, "DOI": "10.1093/jac/dku426", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84928171874&origin=inward", "Abstract": "\u00a9 The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.Objectives: It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART. Methods: This Europe-wide case-control study included ART-naive subjects infected with drug-susceptible HIV-1 as revealed by population sequencing, who achieved virological suppression on first-line ART including one NNRTI. Cases experienced virological failure and controls were subjects from the same cohort whose viraemia remained suppressed at a matched time since initiation of ART. Blinded, centralized 454 pyrosequencing with parallel bioinformatic analysis in two laboratories was used to identify MVs in the 1%-25% frequency range. ORs of virological failure according to MV detection were estimated by logistic regression. Results: Two hundred and sixty samples (76 cases and 184 controls), mostly subtype B (73.5%),were used for the analysis. Identical MVs were detected in the two laboratories. 31.6% of cases and 16.8% of controls harboured pre-existing MVs. Detection of at least one MV versus no MVs was associated with an increased risk of virological failure (OR=2.75, 95% CI=1.35-5.60, P=0.005); similar associations were observed for at least one MV versus no NRTIMVs (OR=2.27, 95% CI=0.76-6.77, P=0.140) and at least oneMV versus no NNRTIMVs (OR=2.41, 95% CI=1.12-5.18, P=0.024). A dose-effect relationship between virological failure and mutational loadwas found. Conclusions: Pre-existing MVs more than double the risk of virological failure to first-line NNRTI-based ART.", "AuthorKeywords": ["Antiretroviral therapy", "CHAIN", "European multicentre study", "Minority drug-resistant HIV-1 variants"], "IndexKeywords": ["Adult", "Antiretroviral Therapy, Highly Active", "Case-Control Studies", "Cohort Studies", "Computational Biology", "Drug Resistance, Viral", "Europe", "Female", "Genotype", "High-Throughput Nucleotide Sequencing", "HIV Infections", "HIV-1", "Humans", "Male", "Reverse Transcriptase Inhibitors", "Risk Assessment", "Sequence Analysis, DNA", "Treatment Failure", "Young Adult"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84928171874", "SubjectAreas": [["Pharmacology", "PHAR", "3004"], ["Microbiology (medical)", "MEDI", "2726"], ["Infectious Diseases", "MEDI", "2725"], ["Pharmacology (medical)", "MEDI", "2736"]], "AuthorData": {"55134188900": {"Name": "Cozzi-Lepri A.", "AuthorID": "55134188900", "AffiliationID": "60022148", "AffiliationName": "University College London"}, "56601225300": {"Name": "Schultze A.", "AuthorID": "56601225300", "AffiliationID": "60022148", "AffiliationName": "University College London"}, "55809082200": {"Name": "Noguera-Julian M.", "AuthorID": "55809082200", "AffiliationID": "60023020, 60068634", "AffiliationName": "Institut de Recerca de la SIDA IrsiCaixa i Unitat VIH, Universitat Aut\u00f2noma de Barcelona, Universitat de Vic"}, "57220519856": {"Name": "Paredes R.", "AuthorID": "57220519856", "AffiliationID": "60023020, 60068634", "AffiliationName": "Institut de Recerca de la SIDA IrsiCaixa i Unitat VIH, Universitat Aut\u00f2noma de Barcelona, Universitat de Vic"}, "36666027700": {"Name": "Di Giallonardo F.", "AuthorID": "36666027700", "AffiliationID": "60019619, 60012614", "AffiliationName": "Division of Infectious Diseases, Hospital Epidemiology, University Hospital Zurich, University of Zurich"}, "55990862300": {"Name": "Kouyos R.D.", "AuthorID": "55990862300", "AffiliationID": "60019619, 60012614", "AffiliationName": "Division of Infectious Diseases, Hospital Epidemiology, University Hospital Zurich, University of Zurich"}, "7005951278": {"Name": "G\u00fcnthard H.F.", "AuthorID": "7005951278", "AffiliationID": "60019619, 60012614", "AffiliationName": "Division of Infectious Diseases, Hospital Epidemiology, University Hospital Zurich, University of Zurich"}, "6603710238": {"Name": "Metzner K.J.", "AuthorID": "6603710238", "AffiliationID": "60019619, 60012614", "AffiliationName": "Division of Infectious Diseases, Hospital Epidemiology, University Hospital Zurich, University of Zurich"}, "56898703600": {"Name": "Schuurman R.", "AuthorID": "56898703600", "AffiliationID": "60032724", "AffiliationName": "Department of Virology, University Medical Centre"}, "54410287400": {"Name": "Aitken S.", "AuthorID": "54410287400", "AffiliationID": "60032724", "AffiliationName": "Department of Virology, University Medical Centre"}, "35866879300": {"Name": "D\u00e4umer M.", "AuthorID": "35866879300", "AffiliationID": "101792112", "AffiliationName": "Institut f\u00fcr Immunologie und Genetik"}, "55882691600": {"Name": "Ceccherini-Silberstein F.", "AuthorID": "55882691600", "AffiliationID": "60027509", "AffiliationName": "Department of Experimental Medicine and Surgery, University of Rome Tor Vergata"}, "34572443100": {"Name": "Monforte A.D.A.", "AuthorID": "34572443100", "AffiliationID": "60030318, 60016182", "AffiliationName": "Department of Health Sciences, Clinic of Infectious Diseases, 'San Paolo' Hospital, University of Milan"}, "6701366859": {"Name": "Geretti A.M.", "AuthorID": "6701366859", "AffiliationID": "60020661", "AffiliationName": "Institute of Infection and Global Health, University of Liverpool"}, "55434411800": {"Name": "Booth C.L.", "AuthorID": "55434411800", "AffiliationID": "60170516", "AffiliationName": "Department of Virology, Royal Free London NHS Foundation Trust"}, "56898513600": {"Name": "Kaiser R.", "AuthorID": "56898513600", "AffiliationID": "60024025", "AffiliationName": "Institute of Virology, University of Cologne"}, "35097615200": {"Name": "Michalik C.", "AuthorID": "35097615200", "AffiliationID": "60024025", "AffiliationName": "Clinical Trial Centre (ZKS), University of Cologne"}, "33667576000": {"Name": "Jansen K.", "AuthorID": "33667576000", "AffiliationID": "60005322", "AffiliationName": "Clinic for Dermatology, Venerology and Allergology, Ruhr-Universit\u00e4t"}, "7006022786": {"Name": "Brockmeyer N.", "AuthorID": "7006022786", "AffiliationID": "60005322", "AffiliationName": "Clinic for Dermatology, Venerology and Allergology, Ruhr-Universit\u00e4t"}, "7003376028": {"Name": "Masquelier B.", "AuthorID": "7003376028", "AffiliationID": "60021564, 60102125, 60106859", "AffiliationName": "Laboratoire de Virologie, CHU de Bordeaux and MFP-UMR5234, Universit\u00e9 Bordeaux 2"}, "15724659600": {"Name": "Bellecave P.", "AuthorID": "15724659600", "AffiliationID": "60021564, 60102125, 60106859", "AffiliationName": "Laboratoire de Virologie, CHU de Bordeaux and MFP-UMR5234, Universit\u00e9 Bordeaux 2"}, "7102441972": {"Name": "Castro E.", "AuthorID": "7102441972", "AffiliationID": "60023561", "AffiliationName": "Addiction Medicine, Service of Community Psychiatry, Centre Hospitalier Universitaire Vaudois"}, "35225781600": {"Name": "Furrer H.", "AuthorID": "35225781600", "AffiliationID": "60010987, 60020486", "AffiliationName": "Department of Infectious Diseases, Bern University Hospital, University of Bern"}, "7006721524": {"Name": "Brun-Vezinet F.", "AuthorID": "7006721524", "AffiliationID": "60022785", "AffiliationName": "Department of Virology, Bichat University Hospital"}}}